Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy.
Raman MC, Rizkallah PJ, Simmons R, Donnellan Z, Dukes J, Bossi G, Le Provost GS, Todorov P, Baston E, Hickman E, Mahon T, Hassan N, Vuidepot A, Sami M, Cole DK, Jakobsen BK.
Raman MC, et al.
Sci Rep. 2016 Jan 13;6:18851. doi: 10.1038/srep18851.
Sci Rep. 2016.
PMID: 26758806
Free PMC article.